For the quarter ending 2025-09-30, GCAN had -$5,357 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
| Net income (loss) | -36,099 | -390,853 | -242,417 |
| Amortization of right of first refusal agreement cost | 0 | 0 | 417 |
| Issuance of common stock for debt conversion | - | - | 57,920 |
| Issuance of common stock for compensation | 0 | 0 | 1,800 |
| Issuance of common stock for accrued compensation | 0 | 10,000 | - |
| Loss on conversion of notes payable | 0 | 232,220 | - |
| Note default penalties and interest | 0 | 306,323 | - |
| Accounts payable | 2,056 | -1,251 | 165 |
| Accrued interest | -1,314 | 886 | 2,054 |
| Note default penalties and interest | - | - | 138,906 |
| Accrued officers compensation | 30,000 | 20,000 | 30,000 |
| Net cash used in operating activities | -5,357 | -19,501 | -11,155 |
| Purchase of right of first refusal agreement | - | - | 0 |
| Net cash used in investing activities | - | 0 | 0 |
| Proceeds from notes payable to third parties | - | - | 0 |
| Net cash provided by financing activities | - | 0 | 0 |
| Net increase (decrease) in cash | -5,357 | -19,501 | -11,155 |
| Cash and cash equivalents at beginning of period | 57,368 | - | - |
| Cash and cash equivalents at end of period | 21,355 | - | - |
Greater Cannabis Company, Inc. (GCAN)
Greater Cannabis Company, Inc. (GCAN)